Maria Pilar Lobera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Pilar Lobera has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Jesus Santamaria
Instituto de Nanociencia y Materiales de Aragón (INMA) CSIC‐Universidad de Zaragoza Zaragoza Spain
5 shared publications - Antonio Tabernero
Department of Chemical Engineering, University of Salamanca, Plaza de los Caídos s/n, 37001, Salamanca, Spain; Institute of Biomedical Research, Hospital Virgen de la Vega, Paseo San Vicente 58-182, 37007, Salamanca, Spain
2 shared publications - Eva María Martín del Valle
Department of Chemical Engineering , University of Salamanca , Salamanca , Spain
2 shared publications - Francisco Balas
Instituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza, Campus Rio Ebro, Edificio I + D + I, C/Poeta Mariano Esquillor, S/n, Zaragoza 50018, Spain
2 shared publications - Javier Calzada
Departamento de Tecnología de Alimentos, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA-CSIC), Carretera de La Coruña km 7, 28040 Madrid, Spain
2 shared publications - María Bernechea
ICFO-Institut de Ciencies Fotoniques, The Barcelona Institute of Science and Technology, 08860 Castelldefels (Barcelona), Spain
2 shared publications
Latest Publications
- Open Access
- 28 February 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 11 (12) , 6258-6273
A double-redox aqueous capacitor with high energy output
The paper puts forward the concept of a double-redox electrochemical capacitor operating in an aqueous electrolyte. The redox activity of sulphur from insoluble Bi2S3 nanocrystals embedded in the negative electrode material (up to 10 wt%) operating in 1 mol L−1 Li2SO4 electrolyte is demonstrated. It is also shown that the performance is significantly boosted using MPA (3-mercaptopropionic acid) as a ligand attached to the surface of the nanocrystals, which allows for more efficient use of Bi2S3 redox active species. This redox activity is combined with the reactions of iodides, which occur at the opposite electrode with 1 mol L−1 NaI. This enables the formation of a discharge voltage plateau that effectively boosts the capacitance (275 F g−1), and thus specific energy of the device owing to the relatively high cell voltage of 1.5 V. This performance is possible due to the advantageous electrode mass ratio (m− : m+ = 2 : 1), which helps to balance the charge. The rate capability test of the device demonstrates its capacitance retention of 73% at 10 A g−1 of the discharge current. The different states of the redox species ensure their operation at separate electrodes in an immiscible manner without a shuttling effect. The specific interactions of the redox active species with carbon electrodes are supported by operando Raman spectroscopy.
- 28 February 2023
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
- Vol. 11 (12) , 6258-6273
Open AccessA double-redox aqueous capacitor with high energy output
The paper puts forward the concept of a double-redox electrochemical capacitor operating in an aqueous electrolyte. The redox activity of sulphur from insoluble Bi2S3 nanocrystals embedded in the negative electrode material (up to 10 wt%) operating in 1 mol L−1 Li2SO4 electrolyte is demonstrated. It is also shown that the performance is significantly boosted using MPA (3-mercaptopropionic acid) as a ligand attached to the surface of the nanocrystals, which allows for more efficient use of Bi2S3 redox active species. This redox activity is combined with the reactions of iodides, which occur at the opposite electrode with 1 mol L−1 NaI. This enables the formation of a discharge voltage plateau that effectively boosts the capacitance (275 F g−1), and thus specific energy of the device owing to the relatively high cell voltage of 1.5 V. This performance is possible due to the advantageous electrode mass ratio (m− : m+ = 2 : 1), which helps to balance the charge. The rate capability test of the device demonstrates its capacitance retention of 73% at 10 A g−1 of the discharge current. The different states of the redox species ensure their operation at separate electrodes in an immiscible manner without a shuttling effect. The specific interactions of the redox active species with carbon electrodes are supported by operando Raman spectroscopy.
- Open Access
- 9 December 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2763
Engineering Alginate-Based Dry Powder Microparticles to a Size Suitable for the Direct Pulmonary Delivery of Antibiotics
The inhaled route is regarded as one of the most promising strategies as a treatment against pulmonary infections. However, the delivery of drugs in a dry powder form remains challenging. In this work, we have used alginate to form microparticles containing an antibiotic model (colistin sulfate). The alginate microparticles were generated by atomization technique, and they were characterized by antimicrobial in vitro studies against Pseudomonas aeruginosa. Optimization of different parameters allowed us to obtain microparticles as a dry powder with a mean size (Feret diameter) of 4.45 ± 1.40 µm and drug loading of 8.5 ± 1.50%. The process developed was able to concentrate most of the colistin deposits on the surface of the microparticles, which could be observed by SEM and a Dual-Beam microscope. This produces a fast in vitro release of the drug, with a 100% release achieved in 4 h. Physicochemical characterization using the FTIR, EDX and PXRD techniques revealed information about the change that occurs from the amorphous to a crystalline form of colistin. Finally, the cytotoxicity of microparticles was tested using lung cell lines (A549 and Calu-3). Results of the study showed that alginate microparticles were able to inhibit bacterial growth while displaying non-toxicity toward lung cells.
- 9 December 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2763
Open AccessEngineering Alginate-Based Dry Powder Microparticles to a Size Suitable for the Direct Pulmonary Delivery of Antibiotics
The inhaled route is regarded as one of the most promising strategies as a treatment against pulmonary infections. However, the delivery of drugs in a dry powder form remains challenging. In this work, we have used alginate to form microparticles containing an antibiotic model (colistin sulfate). The alginate microparticles were generated by atomization technique, and they were characterized by antimicrobial in vitro studies against Pseudomonas aeruginosa. Optimization of different parameters allowed us to obtain microparticles as a dry powder with a mean size (Feret diameter) of 4.45 ± 1.40 µm and drug loading of 8.5 ± 1.50%. The process developed was able to concentrate most of the colistin deposits on the surface of the microparticles, which could be observed by SEM and a Dual-Beam microscope. This produces a fast in vitro release of the drug, with a 100% release achieved in 4 h. Physicochemical characterization using the FTIR, EDX and PXRD techniques revealed information about the change that occurs from the amorphous to a crystalline form of colistin. Finally, the cytotoxicity of microparticles was tested using lung cell lines (A549 and Calu-3). Results of the study showed that alginate microparticles were able to inhibit bacterial growth while displaying non-toxicity toward lung cells.
- Open Access
Tuning Alginate Microparticle Size via Atomization of Non-Newtonian Fluids
A new approach based on the atomization of non-Newtonian fluids has been proposed to produce microparticles for a potential inhalation route. In particular, different solutions of alginate were atomized on baths of different crosslinkers, piperazine and barium chloride, obtaining microparticles around 5 and 40 microns, respectively. These results were explained as a consequence of the different viscoelastic properties, since oscillatory analysis indicated that the formed hydrogel beads with barium chloride had a higher storage modulus (1000 Pa) than the piperazine ones (20 Pa). Pressure ratio (polymer solution-air) was identified as a key factor, and it should be from 0.85 to 1.00 to ensure a successful atomization, obtaining the smallest particle size at intermediate pressures. Finally, a numerical study based on dimensionless numbers was performed to predict particle size depending on the conditions. These results highlight that it is possible to control the microparticles size by modifying either the viscoelasticity of the hydrogel or the experimental conditions of atomization. Some experimental conditions (using piperazine) reduce the particle size up to 5 microns and therefore allow their use by aerosol inhalation.
Open AccessTuning Alginate Microparticle Size via Atomization of Non-Newtonian Fluids
A new approach based on the atomization of non-Newtonian fluids has been proposed to produce microparticles for a potential inhalation route. In particular, different solutions of alginate were atomized on baths of different crosslinkers, piperazine and barium chloride, obtaining microparticles around 5 and 40 microns, respectively. These results were explained as a consequence of the different viscoelastic properties, since oscillatory analysis indicated that the formed hydrogel beads with barium chloride had a higher storage modulus (1000 Pa) than the piperazine ones (20 Pa). Pressure ratio (polymer solution-air) was identified as a key factor, and it should be from 0.85 to 1.00 to ensure a successful atomization, obtaining the smallest particle size at intermediate pressures. Finally, a numerical study based on dimensionless numbers was performed to predict particle size depending on the conditions. These results highlight that it is possible to control the microparticles size by modifying either the viscoelasticity of the hydrogel or the experimental conditions of atomization. Some experimental conditions (using piperazine) reduce the particle size up to 5 microns and therefore allow their use by aerosol inhalation.
- 1 December 2021
- Published by Elsevier in Carbohydrate Polymers
- Vol. 273, 118543
Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray
- 1 December 2021
- Published by Elsevier in Carbohydrate Polymers
- Vol. 273, 118543
Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray
- Open Access
- 23 November 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (12) , 1988
Excipient-Free Inhalable Microparticles of Azithromycin Produced by Electrospray: A Novel Approach to Direct Pulmonary Delivery of Antibiotics
Inhalation therapy offers several advantages in respiratory disease treatment. Azithromycin is a macrolide antibiotic with poor solubility and bioavailability but with a high potential to be used to fight lung infections. The main objective of this study was to generate a new inhalable dry powder azithromycin formulation. To this end, an electrospray was used, yielding a particle size around 2.5 µm, which is considered suitable to achieve total deposition in the respiratory system. The physicochemical properties and morphology of the obtained microparticles were analysed with a battery of characterization techniques. In vitro deposition assays were evaluated after aerosolization of the powder at constant flow rate (100 L/min) and the consideration of the simulation of two different realistic breathing profiles (healthy and chronic obstructive pulmonary disease (COPD) patients) into a next generation impactor (NGI). The formulation was effective in vitro against two types of bacteria, Staphylococcus aureus and Pseudomonas aeruginosa. Finally, the particles were biocompatible, as evidenced by tests on the alveolar cell line (A549) and bronchial cell line (Calu-3).
- 23 November 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (12) , 1988
Open AccessExcipient-Free Inhalable Microparticles of Azithromycin Produced by Electrospray: A Novel Approach to Direct Pulmonary Delivery of Antibiotics
Inhalation therapy offers several advantages in respiratory disease treatment. Azithromycin is a macrolide antibiotic with poor solubility and bioavailability but with a high potential to be used to fight lung infections. The main objective of this study was to generate a new inhalable dry powder azithromycin formulation. To this end, an electrospray was used, yielding a particle size around 2.5 µm, which is considered suitable to achieve total deposition in the respiratory system. The physicochemical properties and morphology of the obtained microparticles were analysed with a battery of characterization techniques. In vitro deposition assays were evaluated after aerosolization of the powder at constant flow rate (100 L/min) and the consideration of the simulation of two different realistic breathing profiles (healthy and chronic obstructive pulmonary disease (COPD) patients) into a next generation impactor (NGI). The formulation was effective in vitro against two types of bacteria, Staphylococcus aureus and Pseudomonas aeruginosa. Finally, the particles were biocompatible, as evidenced by tests on the alveolar cell line (A549) and bronchial cell line (Calu-3).
- 1 June 2018
- Published by Elsevier in Science of The Total Environment
- Vol. 625, 978-986
A versatile generator of nanoparticle aerosols. A novel tool in environmental and occupational exposure assessment
- 1 June 2018
- Published by Elsevier in Science of The Total Environment
- Vol. 625, 978-986
A versatile generator of nanoparticle aerosols. A novel tool in environmental and occupational exposure assessment
- Open Access
- 13 January 2017
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 4 (3) , 670-678
Modeling the size distribution in a fluidized bed of nanopowder
The release of nanosized particles from fluidized beds of ceramic oxide nanopowders, namely, TiO2(P25), Al2O3(AluC) and SiO2(A130) has been assessed for the first time.
- 13 January 2017
- Published by Royal Society of Chemistry (RSC) in Environmental Science: Nano
- Vol. 4 (3) , 670-678
Open AccessModeling the size distribution in a fluidized bed of nanopowder
The release of nanosized particles from fluidized beds of ceramic oxide nanopowders, namely, TiO2(P25), Al2O3(AluC) and SiO2(A130) has been assessed for the first time.